Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-24T02:41:56.115Z Has data issue: false hasContentIssue false
  • English
  • Français

Medical Pharmaceuticals and Distributive Justice

Published online by Cambridge University Press:  18 December 2007

MICHAEL BOYLAN
MICHAEL BOYLAN
Affiliation:
Department of Philosophy, Marymount University, Arlington, Virginia
Get access Rights & Permissions [Opens in a new window]

Extract

There are deep structural conflicts between the mission of healthcare as cooperative care to the sick and injured and that of healthcare as a business whose mission is maximizing profits. These conflicts come to the fore in the medical pharmaceutical industry. I first set these out in a context that addresses the mission of healthcare, then examine the relative roles of competitive and cooperative systems of distributive justice, and then argue for the creation of nonprofit pharmaceutical companies and the transformation of many for-profit companies into companies subject to public oversight and profit curbs. The recommendations are aspirational for the United States (because it does not yet offer universal health coverage) but it is meant to be action guiding for those industrialized countries wealthy enough to provide universal health coverage.

Type
SPECIAL SECTION: OPEN FORUM
Information
Cambridge Quarterly of Healthcare Ethics , Volume 17 , Issue 1 , January 2008 , pp. 30 - 44
Copyright
© 2008 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)